In this issue:
Tegoprazan, a potassiumcompetitive acid blocker, for erosive oesophagitis
Optimising infliximab monotherapy and combination therapy in IBD
SIBO prevalence in IBD
H. pylori eradication: modified dual vs. bismuth-containing quad therapy
Abrilumab for moderate-to-severe UC
Consecutive colonoscopies for predicting advanced neoplasia risk in IBD with chronic colitis
Zhizhu Kuanzhong, a traditional Chinese medicine, for postprandial distress syndrome
Novel leucocyte/thrombocyte apheresis induces steroid-free remission in UC
Please login below to download this issue (PDF)